Nyxoah NYXH
NASDAQ NYXH
$1.60 -0.04 (-2.74%)
At close: Aug 21, 2026 · 4:00 PM EDT

Nyxoah (NYXH) Net Income towards Common Stockholders (2021 - 2026)

Nyxoah (NYXH) posted quarterly Net Income towards Common Stockholders of $19.0 million for Q1 2026, down 19.19% year-over-year from $23.5 million in Q1 2025, and down 99.93% quarter-over-quarter from $27.4 billion in Q4 2025.

Nyxoah (NYXH) Net Income towards Common Stockholders (2021 - 2026) Analysis & Trends

Nyxoah's Net Income towards Common Stockholders history runs 6 years deep, the most recent figure standing at $19.0 million for Q1 2026.

  • In Q1 2026, Net Income towards Common Stockholders fell 19.19% year-over-year to $19.0 million; the TTM figure through Mar 2026 stood at $27.4 billion (up 249.9% YoY), while the FY2025 annual figure was -$104.9 million, down 65.66% from the prior year.
  • Net Income towards Common Stockholders for Q1 2026 stood at $19.0 million, down from $27.4 billion in the prior quarter.
  • The five-year high for Net Income towards Common Stockholders was $27.4 billion in Q4 2025, with the low at -$18.3 billion in Q4 2024.
  • The 5-year median for Net Income towards Common Stockholders is $14.0 million (2023), against an average of $1.4 billion.
  • The sharpest annual moves came in 2023 and 2025: Net Income towards Common Stockholders surged 167934.78% in 2023, then tumbled 245.57% in 2025.
  • Nyxoah's Net Income towards Common Stockholders stood at $13.6 billion in 2022, then slumped by 186.32% to -$11.7 billion in 2023, then tumbled by 56.36% to -$18.3 billion in 2024, then jumped by 249.36% to $27.4 billion in 2025, then plunged by 99.93% to $19.0 million in 2026.
  • Business Quant data shows NYXH's Net Income towards Common Stockholders at $19.0 million in Q1 2026, $27.4 billion in Q4 2025, and -$27.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn 823.20 Mn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn 378.00 Mn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn -
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn 383.43 Mn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn 139.00 Mn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn 147.90 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn 93.00 Mn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn -77.90 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn 126.00 Mn
10 Nyxoah 90.94 Mn 90.94 Mn 5.33 Mn -38.32 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -38.32 Mn
Mar 31, 2026 19.03 Mn
Dec 31, 2025 27.37 Bn
Sep 30, 2025 -27.60 Mn
Jun 30, 2025 23.06 Mn
Mar 31, 2025 23.55 Mn
Dec 31, 2024 -18.33 Bn
Sep 30, 2024 18.96 Mn
Jun 30, 2024 14.22 Mn
Mar 31, 2024 12.93 Mn
Dec 31, 2023 -11.72 Bn
Sep 30, 2023 -8.30 Mn
Jun 30, 2023 13.99 Mn
Mar 31, 2023 12.81 Bn
Dec 31, 2022 13.58 Bn
Sep 30, 2022 -6.29 Mn
Jun 30, 2022 5.34 Mn
Mar 31, 2022 -7.64 Mn
Dec 31, 2021 7.24 Bn
Sep 30, 2021 10.40 Mn